50+ Years of
Manufacturing Heritage
Established Australian facilities shaped by a global pharmaceutical legacy, delivering end-to-end biologics drug substance and world-class sterile fill-finish manufacturing from clinical development through to commercial supply.
Five Decades of Proven Manufacturing Capability
Read the Full Story
From global pharmaceutical operations to an independent CDMO. Discover how fifty years of manufacturing excellence became BioCina.
Full Story
What Sets Us Apart
True Agility
Built to move at the pace your program demands, we work with you to shape the right approach, adapting to your timelines and scientific requirements without constraints.
Globally Approved
Our facilities have received approvals from some of the world's most demanding regulatory authorities, including FDA, TGA, EMA, Health Canada, and ANVISA, supporting product supply to more than 140 countries worldwide.
Built on Partnership
Transparent communication, one accountable contact, and a team genuinely invested in your program's success from first batch through to commercial supply.
Facilities & Virtual Tours
Explore our facilities through immersive private virtual walkthroughs. Connect with us to arrange a tour.
Book a Tour
Backed by BridgeWest
BioCina is backed by BridgeWest Group, a global investment firm with US$3B+ in assets and a strategic network of 40+ life sciences and technology portfolio companies across Australia, New Zealand, and beyond.
BridgeWest's long-term ownership model drives sustained capital investment in BioCina's capabilities, infrastructure, and innovation, giving clients confidence in a manufacturing partner built for the long term.
Ready to Move Forward? Australia Works for You.
Partner with BioCina and unlock Australia's competitive edge
for your program.
